189 related articles for article (PubMed ID: 22278227)
1. Hepatitis C virus infection of human T lymphocytes is mediated by CD5.
Sarhan MA; Pham TN; Chen AY; Michalak TI
J Virol; 2012 Apr; 86(7):3723-35. PubMed ID: 22278227
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of candidate virus receptors in human T lymphocytes prone or resistant to infection with patient-derived hepatitis C virus.
Sarhan MA; Chen AY; Michalak TI
PLoS One; 2013; 8(4):e62159. PubMed ID: 23626783
[TBL] [Abstract][Full Text] [Related]
3. Expansion of peripheral blood CD5+ B cells is associated with mild disease in chronic hepatitis C virus infection.
Curry MP; Golden-Mason L; Nolan N; Parfrey NA; Hegarty JE; O'Farrelly C
J Hepatol; 2000 Jan; 32(1):121-5. PubMed ID: 10673076
[TBL] [Abstract][Full Text] [Related]
4. Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection.
Zuckerman E; Slobodin G; Kessel A; Sabo E; Yeshurun D; Halas K; Toubi E
Clin Exp Immunol; 2002 May; 128(2):353-8. PubMed ID: 11985527
[TBL] [Abstract][Full Text] [Related]
5. Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection.
Cacoub P; Bourlière M; Hausfater P; Charlotte F; Khiri H; Toci S; Piette JC; Poynard T; Halfon P
J Viral Hepat; 2003 Jan; 10(1):10-5. PubMed ID: 12558906
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C Virus Infection of Human Thyrocytes: Metabolic, Hormonal, and Immunological Implications.
Hammerstad SS; Blackard JT; Lombardi A; Owen RP; Concepcion E; Yi Z; Zhang W; Tomer Y
J Clin Endocrinol Metab; 2020 Apr; 105(4):1157-68. PubMed ID: 31784757
[TBL] [Abstract][Full Text] [Related]
7. Patient-derived hepatitis C virus inhibits CD4⁺ but not CD8⁺ T lymphocyte proliferation in primary T cells.
MacParland SA; Chen AY; Corkum CP; Pham TN; Michalak TI
Virol J; 2015 Jun; 12():93. PubMed ID: 26084511
[TBL] [Abstract][Full Text] [Related]
8. CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes.
Ye L; Wang X; Wang S; Wang Y; Song L; Hou W; Zhou L; Li H; Ho W
Hepatology; 2009 Mar; 49(3):753-62. PubMed ID: 19085952
[TBL] [Abstract][Full Text] [Related]
9. Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver.
Mitchell AM; Stone AE; Cheng L; Ballinger K; Edwards MG; Stoddard M; Li H; Golden-Mason L; Shaw GM; Khetani S; Rosen HR
mBio; 2015 Feb; 6(2):e02510. PubMed ID: 25714713
[TBL] [Abstract][Full Text] [Related]
10. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
[TBL] [Abstract][Full Text] [Related]
11. Patient-derived hepatitis C virus and JFH-1 clones differ in their ability to infect human hepatoma cells and lymphocytes.
Sarhan MA; Chen AY; Russell RS; Michalak TI
J Gen Virol; 2012 Nov; 93(Pt 11):2399-2407. PubMed ID: 22855787
[TBL] [Abstract][Full Text] [Related]
12. Role of T cell immunity in hepatitis C virus infections.
Claassen MA; Janssen HL; Boonstra A
Curr Opin Virol; 2013 Aug; 3(4):461-7. PubMed ID: 23735335
[TBL] [Abstract][Full Text] [Related]
13. [HCV infection and specific T lymphocyte immunity].
Shi JJ; Zhang JY; Zhang XX; Wang FS
Zhonghua Gan Zang Bing Za Zhi; 2016 Mar; 24(3):170-4. PubMed ID: 27095758
[TBL] [Abstract][Full Text] [Related]
14. Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients.
Douam F; Bobay LM; Maurin G; Fresquet J; Calland N; Maisse C; Durand T; Cosset FL; Féray C; Lavillette D
J Virol; 2016 Jan; 90(2):992-1008. PubMed ID: 26537674
[TBL] [Abstract][Full Text] [Related]
15. Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.
Sautto GA; Wisskirchen K; Clementi N; Castelli M; Diotti RA; Graf J; Clementi M; Burioni R; Protzer U; Mancini N
Gut; 2016 Mar; 65(3):512-23. PubMed ID: 25661083
[TBL] [Abstract][Full Text] [Related]
16. Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver.
Curry MP; Golden-Mason L; Doherty DG; Deignan T; Norris S; Duffy M; Nolan N; Hall W; Hegarty JE; O'Farrelly C
J Hepatol; 2003 May; 38(5):642-50. PubMed ID: 12713876
[TBL] [Abstract][Full Text] [Related]
17. [Physiopathology of HCV infection].
Zarski JP; Souvignet C
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B154-62. PubMed ID: 12180283
[No Abstract] [Full Text] [Related]
18. Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients.
Sansonno D; Iacobelli AR; Cornacchiulo V; Iodice G; Dammacco F
Clin Exp Immunol; 1996 Mar; 103(3):414-21. PubMed ID: 8608640
[TBL] [Abstract][Full Text] [Related]
19. CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.
Rau SJ; Hildt E; Himmelsbach K; Thimme R; Wakita T; Blum HE; Fischer R
Hepatology; 2013 Jan; 57(1):23-36. PubMed ID: 22814930
[TBL] [Abstract][Full Text] [Related]
20. The 1F7 idiotype is selectively expressed on CD5+ B cells and elevated in chronic hepatitis C virus infection.
Davtyan TK; Hovsepyan MP; Mkhitaryan LM; Hakobyan GS; Brazil A; Barrett L; Hirsch G; Peltekian KM; Grant MD
Immunol Cell Biol; 2009; 87(6):457-63. PubMed ID: 19333248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
